发明名称 |
CONTINUOUS ARYCYCLIC COMPOUND. |
摘要 |
This is to provide a continuous arycyclic compound having a DGAT1 inhibitory activity, and useful for prophylaxis and/or treatment of obesity or hyperlipidemia caused by obesity, hypertriglyceridemia, lipid metabolism disorder, fatty liver, hypertension, arteriosclerosis, diabetes, etc., as well as to provide a DGAT1 inhibitor comprising the continuous arycyclic compound or a pharmaceutically acceptable salt thereof as an effective ingredient. Disclosed is the continuous arycyclic compound is represented by the formula: wherein the substituents in the formula are the same as defined in the specification, or a pharmaceutically acceptable salt thereof. |
申请公布号 |
MX2013006874(A) |
申请公布日期 |
2013.07.05 |
申请号 |
MX20130006874 |
申请日期 |
2011.12.16 |
申请人 |
MITSUBISHI TANABE PHARMA CORPORATION |
发明人 |
HAYASHI, NORIMITSU;SAKURAI, OSAMU;SARUTA, KUNIO;GOI, TAKASHI;MOROKUMA, KENJI;TSUJISHIMA, HIDEKAZU;SAWAMOTO, HIROAKI;SHITAMA, HIROAKI;IMASHIRO, RITSUO |
分类号 |
C07D401/04;A61K31/4164;A61K31/44;A61K31/497;A61K31/506;A61P3/04;A61P3/06;A61P3/10;A61P9/10;A61P9/12;A61P43/00;C07D233/64;C07D401/10;C07D401/14;C07D403/04;C07D403/10 |
主分类号 |
C07D401/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|